← Back to Search

Behavioral Intervention

Family Support Program for Autism

N/A

Recruiting

Led By Mei Elansary, MD

Research Sponsored by Boston Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will investigate if an adapted intervention helps families of autistic youth in a hospital setting. Parents & youth meet separately in 1 session & 4 2.5hr multi-family groups.

Who is the study for?

This trial is for families with a youth aged 14-21 diagnosed with autism, who have visited BMC since 2015 and are in high school or specialized schooling. Parents must be comfortable with English/Spanish and live with the youth.

What is being tested?

The study tests 'Transitioning Together/Juntos en la Transición,' an intervention involving one family session and four group sessions to improve outcomes for families dealing with autism transitions.

What are the potential side effects?

Since this is a psychoeducational intervention, there may not be physical side effects like those seen in drug trials. However, participants might experience emotional discomfort or stress during discussions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in quality of life of autistic youth

Change in transition-related goal attainment

Abnormal behavior

Secondary study objectives

Change in coping

Change in family climate

Change in family empowerment

+4 more

Other study objectives

Intervention Engagement

Intervention Satisfaction

Intervention acceptability, appropriateness, and feasibility

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Transitioning TogetherExperimental Treatment1 Intervention

Participants in this arm will receive the Transitioning Together intervention in English or Spanish either at BMC, at BMC's Supporting Parents \& Resilient Kids (SPARK) Center or on BMC Zoom.

Group II: Usual CareActive Control1 Intervention

Participants in this arm will receive a referral to usual transition-related care through the BMC Developmental and Behavioral Pediatrics (DBP) clinic/the BMC Autism Program.

Do I qualify?Apply below to find out